Patient resources*
We’re committed to helping patients access Amgen medicines whenever possible.
Please see Full Prescribing Information, including Boxed WARNINGS, and Medication Guide for RIABNI™.
All Products
- Access Resources
- Resources
For eligible† commercially insured patients
The Amgen FIRST STEP™ program can help you meet your deductible, co-insurance, and co-payment.
- $0 out-of-pocket for first dose or cycle
- As little as $5‡ out of pocket for subsequent doses or cycles, up to the brand program maximum
- No income eligibility requirement
For patients with government insurance like Medicare
We provide referrals to independent nonprofit patient assistance programs that may be able to help them afford the co-pay cost of their medicine.*§
For uninsured patients
Amgen Safety Net Foundation, a nonprofit patient assistance program sponsored by Amgen, helps qualified patients access Amgen medicines at no cost.
Visit Amgen Safety Net FoundationResources to help you get started
Download the access-related forms below to help you enroll patients and execute other administrative tasks.
Reimbursement-Related Form
Sample Letters
*Resources include referrals to independent nonprofit patient assistance programs. Eligibility for resources provided by independent nonprofit patient assistance programs is based on the nonprofits’ criteria. Amgen has no control over these programs and provides referrals as a courtesy only.
†Terms, conditions, and program maximums apply. This program is not open to patients receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program. Not valid where prohibited by law.
‡$25 out-of-pocket cost for subsequent dose or cycle of Prolia® (denosumab); $5 out-of-pocket cost for subsequent dose or cycle of other products through Amgen FIRST STEP™.
§Amgen Assist 360™ can refer patients to independent nonprofit patient assistance programs that may be able to help them afford the co-pay costs for their prescribed medicine.